Web-delivered Provider Intervention for Tobacco Control (QUIT-PRIMO)

This study has been completed.

Sponsor:

Collaborators:

Johns Hopkins University

University of Alabama at Birmingham

Information provided by (Responsible Party):

Thomas Houston, University of Massachusetts, Worcester

ClinicalTrials.gov Identifier:

NCT00797628

First received: November 24, 2008

Last updated: August 27, 2013

Last verified: August 2013

History of Changes

Purpose

This is a randomized control trial to determine the efficacy of a multi-modal intervention in improving smoking cessation processes of care and patient outcomes in community-based primary care practices. Our Overall Goal is to advance science related to the use and impact of the Internet in health services delivery, specifically smoking cessation, by targeting primary care clinical microsystems. A clinical microsystem is defined as the smallest functional healthcare unit. A clinical microsystem is not simply equivalent to a clinical team of doctors and nurses, but also the panel of patients cared for by the providers and the processes of care that are used.

Condition	Intervention
Smoking Cessation	Behavioral: Decide2Quit Behavioral: Smoking Coach


Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Health Services Research
Official Title:	QUIT-PRIMO: Web-Delivered Clinical Microsystem Intervention for Tobacco Control

Resource links provided by NLM:

MedlinePlus related topics: Quitting Smoking Smoking

U.S. FDA Resources

Further study details as provided by University of Massachusetts, Worcester:

Primary Outcome Measures:

Physician performance on refering patients that smoke cigarettes to the web intervention [ Time Frame: pre-intervention, 6 months, 12 months and 24 months ] [ Designated as safety issue: No ]
Of the smokers who are referred to the web intervention, the number who go to the site [ Time Frame: preintervention, 6 months, 12 months, 24 months ] [ Designated as safety issue: No ]
Point prevalence smoking cessation [ Time Frame: 6 months ] [ Designated as safety issue: No ]


Enrollment:	174
Study Start Date:	March 2010
Study Completion Date:	August 2013
Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Information Prescription Providers will give usual care to patients who smoke and a paper prescription with the name and url of the "Smoking Coach" website. The smoking coach website is a tailored, public health intervention for smoking cessation.	Behavioral: Smoking Coach Control Patients will be referred by paper prescription to the control- "Smoking Coach" website.
Experimental: QUIT-PRIMO Providers will give usual care to patients who smoke and then refer patients to the online smoking cessation system electronically.	Behavioral: Decide2Quit Patient intervention website that includes 1) interactive calculators to assess readiness to quit, symptoms and quit plan, 2) motivational content, and 3) links to other high quality information.

Eligibility


Ages Eligible for Study:	19 Years and older (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Community based primary care practices who have:
- Internet access in office
- Sees 4 - 5 smokers per week

Exclusion Criteria:

Practices with more than five providers

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00797628

Locations


United States, Massachusetts
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01655

Sponsors and Collaborators

University of Massachusetts, Worcester

Johns Hopkins University

University of Alabama at Birmingham

Investigators


Principal Investigator:	Thomas K Houston, MD	University of Massachusetts, Worcester

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Houston TK, Sadasivam RS, Allison JJ, Ash AS, Ray MN, English TM, Hogan TP, Ford DE. Evaluating the QUIT-PRIMO clinical practice ePortal to increase smoker engagement with online cessation interventions: a national hybrid type 2 implementation study. Implement Sci. 2015 Nov 2;10:154. doi: 10.1186/s13012-015-0336-8.

Coley HL, Sadasivam RS, Williams JH, Volkman JE, Schoenberger YM, Kohler CL, Sobko H, Ray MN, Allison JJ, Ford DE, Gilbert GH, Houston TK; National Dental PBRN and QUITPRIMO Collaborative Group. Crowdsourced peer- versus expert-written smoking-cessation messages. Am J Prev Med. 2013 Nov;45(5):543-50. doi: 10.1016/j.amepre.2013.07.004.

Sadasivam RS, Kinney RL, Delaughter K, Rao SR, Williams JH, Coley HL, Ray MN, Gilbert GH, Allison JJ, Ford DE, Houston TK; National Dental PBRN Group; QUIT-PRIMO Collaborative Group. Who participates in Web-assisted tobacco interventions? The QUIT-PRIMO and National Dental Practice-Based Research Network Hi-Quit studies. J Med Internet Res. 2013 May 1;15(5):e77. doi: 10.2196/jmir.2385.

Sadasivam RS, Delaughter K, Crenshaw K, Sobko HJ, Williams JH, Coley HL, Ray MN, Ford DE, Allison JJ, Houston TK. Development of an interactive, Web-delivered system to increase provider-patient engagement in smoking cessation. J Med Internet Res. 2011 Oct 18;13(4):e87. doi: 10.2196/jmir.1721.


Responsible Party:	Thomas Houston, Principal Investigator, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:	NCT00797628 History of Changes
Other Study ID Numbers:	X071211009 NIH R01CA129091
Study First Received:	November 24, 2008
Last Updated:	August 27, 2013
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on September 26, 2016

To Top